FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Per Kogner

Research Profile

Disorders

Living Beings

Anatomy

Chemicals & Drugs

Concepts & Ideas

Neoplasm Staging

Procedures

Physiology

Genes & Molecular Sequences

Genes, Tumor Suppressor

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Lena-Maria Carlson; Helena Idborg; Per-Johan Jakobsson; Agnes Rasmuson; Lova Segerström; Baldur Sveinbjörnsson; Per Kogner
Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastoma.
Ingvild Pettersen; Agnes Rasmuson; Jan-Olof Winberg; Svetlana N Zykova; Frida Abel; Wenche H Bakkelund; Ninib Baryawno; John Inge Johnsen; Per Kogner; Ugo Moens; Baldur Sveinbjörnsson
Expression of TWEAK/Fn14 in neuroblastoma: implications in tumorigenesis.
Malin Wickström; Peter G Zaphiropoulos; Ninib Baryawno; Cecilia Dyberg; Ole M Fuskevåg; Per Kogner; Rolf Larsson; Jelena Milosevic; Takashi Shimokawa; John Inge Johnsen
Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Per Kogner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2013: Lena-Maria Carlson; Helena Idborg; Per-Johan Jakobsson; Agnes Rasmuson; Lova Segerström; Baldur Sveinbjörnsson; Per Kogner
Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastoma.
Carcinogenesis 2013;34(5):1081-8.
2013: Ingvild Pettersen; Agnes Rasmuson; Jan-Olof Winberg; Svetlana N Zykova; Frida Abel; Wenche H Bakkelund; Ninib Baryawno; John Inge Johnsen; Per Kogner; Ugo Moens; Baldur Sveinbjörnsson
Expression of TWEAK/Fn14 in neuroblastoma: implications in tumorigenesis.
International journal of oncology 2013;42(4):1239-48.
2013: Malin Wickström; Peter G Zaphiropoulos; Ninib Baryawno; Cecilia Dyberg; Ole M Fuskevåg; Per Kogner; Rolf Larsson; Jelena Milosevic; Takashi Shimokawa; John Inge Johnsen
Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo.
International journal of cancer. Journal international du cancer 2013;132(7):1516-24.
2013: Damini Chand; Edward F Attiyeh; Per Kogner; John Maris; Marco A Marra; Tommy Martinsson; Olena Morozova; Akira Nakagawara; Miki Ohira; Ruth H Palmer; Kristina Ruuth; Per-Erik Sandström; Christina Schönherr; Yasuo Yamazaki; Bengt Hallberg
Cell culture and Drosophila model systems define three classes of anaplastic lymphoma kinase mutations in neuroblastoma.
Disease models & mechanisms 2013;6(2):373-82.
2013: Susanne Fransson; Per Kogner; Tommy Martinsson; Frida Abel; Katarina Ejeskär
Stage-dependent expression of PI3K/Akt‑pathway genes in neuroblastoma.
International journal of oncology 2013;42(2):609-16.
2013: Susanne Fransson; Per Kogner; Tommy Martinsson; Katarina Ejeskär
Aggressive neuroblastomas have high p110alpha but low p110delta and p55alpha/p50alpha protein levels compared to low stage neuroblastomas.
Journal of molecular signaling 2013;8(1):4.
2012: S de Fine Licht; Per Kogner; P M Lähteenmäki; N H Rod; L S Schmidt; Kjeld Schmiegelow; T Stokland; catarina Träger; Joachim Schüz
Hepatoblastoma in the Nordic countries.
International journal of cancer. Journal international du cancer 2012;131(4):E555-61.
2012: H Hiyoshi; John Inge Johnsen; Per Kogner; T K Lundgren; A Miyakawa; M Nuriya; Lova Segerström; Baldur Sveinbjörnsson; S Abdelhady; Michael Andäng; Luc Desfrere; M Yasui; Per Uhlén
Quiescence and γH2AX in neuroblastoma are regulated by ouabain/Na,K-ATPase.
British journal of cancer 2012;106(11):1807-15.
2012: Agnes Rasmuson; Lova Segerström; Tommy Martinsson; Maria Nethander; Staffan Nilsson; L H M Elfman; Jennie Finnman; Niloufar Javanmardi; John Inge Johnsen; Per Kogner
Tumor development, growth characteristics and spectrum of genetic aberrations in the TH-MYCN mouse model of neuroblastoma.
PloS one 2012;7(12):e51297.
2012: Nimrod B Kiss; Per Kogner; Catharina Larsson; Tommy Martinsson; John Inge Johnsen; Janos Geli
Quantitative global and gene-specific promoter methylation in relation to biological properties of neuroblastomas.
BMC medical genetics 2012;13():83.
2012: Anna Djos; Per Kogner; Tommy Martinsson; Helena Carén
The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma.
Molecular cancer 2012;11():40.
2012: A Vilborg; Malin Wickström; C Bersani; Per Kogner; Lova Segerström; K G Wiman
Wig-1, a novel regulator of N-Myc mRNA and N-Myc-driven tumor growth.
Cell death & disease 2012;3():e298.
2012: Agnes Rasmuson; Jaione Simón-Santamaría; Ole Martin Fuskevåg; Vladimir Gogvadze; John Inge Johnsen; Anna Kock; Per Kogner; Björn Kruspig; Baldur Sveinbjörnsson
Autocrine prostaglandin E2 signaling promotes tumor cell survival and proliferation in childhood neuroblastoma.
PloS one 2012;7(1):e29331.
2011: Lova Segerström; Baldur Sveinbjörnsson; Malin Wickström; Ninib Baryawno; Lotta Elfman; Per Kogner; John Inge Johnsen
Effects of small molecule inhibitors of PI3K/Akt/mTOR signaling on neuroblastoma growth in vitro and in vivo.
International journal of cancer. Journal international du cancer 2011;129(12):2958-65.
2011: Paula Schiapparelli; Mehdi H Shahi; Mónica Enguita-Germán; John Inge Johnsen; Per Kogner; Paula Lázcoz; Javier S Castresana
Inhibition of the sonic hedgehog pathway by cyplopamine reduces the CD133+/CD15+ cell compartment and the in vitro tumorigenic capability of neuroblastoma cells.
Cancer letters 2011;310(2):222-31.
2011: Hanna Kryh; Rose-Marie Sjöberg; Jonas Abrahamsson; Irene Devenney; Elsa Jegerås; Per Kogner; Tommy Martinsson
MYCN amplicon junctions as tumor-specific targets for minimal residual disease detection in neuroblastoma.
International journal of oncology 2011;39(5):1063-71.
2011: Ninib Baryawno; Anna Darabi; O-M FuskevÅg; John Inge Johnsen; Zahidul Khan; Per Kogner; Magnus Nordenskjöld; Jenny Odeberg; Afsar Rahbar; Lova Segerström; Peter Siesjö; Baldur Sveinbjörnsson; Chato Taher; Nina Wolmer-Solberg; Cecilia Söderberg-Nauclér
Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target.
The Journal of clinical investigation 2011;121(10):4043-55.
2011: Bjørn Helge Haug; Jørn R Henriksen; Per Kogner; Tommy Martinsson; Baldur Sveinbjørnsson; Ellen Tømte; Jochen Buechner; Trond Flaegstad; Dirk Geerts; Christer Einvik
MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma.
Carcinogenesis 2011;32(7):1005-12.
2011: Joachim Schüz; Lisbeth Samsø Schmidt; Per Kogner; Päivi M Lähteenmäki; Niklas Pal; Tore Stokland; Kjeld Schmiegelow
Birth characteristics and Wilms tumors in children in the Nordic countries: a register-based case-control study.
International journal of cancer. Journal international du cancer 2011;128(9):2166-73.
2011: Helena Gleissman; Lova Segerström; Mats Hamberg; Frida Ponthan; Magnus Lindskog; John Inge Johnsen; Per Kogner
Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo.
International journal of cancer. Journal international du cancer 2011;128(7):1703-11.
2011: Hanna Kryh; Rose-Marie Sjöberg; Jonas Abrahamsson; Helena Carén; Jennie Erichsen; Per Kogner; Tommy Martinsson
Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors.
BMC genomics 2011;12():443.
2011: Frida Abel; Daniel Dalevi; Maria Nethander; Rebecka Jörnsten; Katleen De Preter; Joëlle Vermeulen; Raymond Stallings; Per Kogner; John M Maris; Staffan Nilsson
A 6-gene signature identifies four molecular subgroups of neuroblastoma.
Cancer cell international 2011;11():9.
2011: Helena Carén; Anna Djos; Maria Nethander; Rose-Marie Sjöberg; Per Kogner; Camilla Enström; Staffan Nilsson; Tommy Martinsson
Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma.
BMC cancer 2011;11():66.
2011: Tommy Martinsson; Therese Eriksson; Jonas Abrahamsson; Helena Caren; Magnus Hansson; Per Kogner; Sattu Kamaraj; Christina Schönherr; Joel Weinmar; Kristina Ruuth; Ruth H Palmer; Bengt Hallberg
Appearance of the novel activating F1174S ALK mutation in neuroblastoma correlates with aggressive tumor progression and unresponsiveness to therapy.
Cancer research 2011;71(1):98-105.
2010: Janos Geli; Nimrod Kiss; Per Kogner; Catharina Larsson
Suppression of RIZ in biologically unfavourable neuroblastomas.
International journal of oncology 2010;37(5):1323-30.
2010: Ruth Ladenstein; Dominique Valteau-Couanet; Penelope Brock; Isaac Yaniv; Victoria Castel; Geneviève Laureys; Josef Malis; Vassilios Papadakis; Ana Lacerda; Ellen Ruud; Per Kogner; Miklos Garami; Walentyna Balwierz; Henrik Schroeder; Maja Beck Popovic; Guenter Schreier; David Machin; Ulrike Pötschger; Andrew Pearson
Randomized Trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma: the European HR-NBL1/SIOPEN study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(21):3516-24.
2010: Ninib Baryawno; Baldur Sveinbjörnsson; Per Kogner; John Inge Johnsen
Medulloblastoma: a disease with disorganized developmental signaling cascades.
Cell cycle (Georgetown, Tex.) 2010;9(13):2548-54.
2010: Helena Gleissman; John Inge Johnsen; Per Kogner
Omega-3 fatty acids in cancer, the protectors of good and the killers of evil?
Experimental cell research 2010;316(8):1365-73.
2010: Helena Carén; Hanna Kryh; Maria Nethander; Rose-Marie Sjöberg; catarina Träger; Staffan Nilsson; Jonas Abrahamsson; Per Kogner; Tommy Martinsson
High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(9):4323-8.
2010: Helena Gleissman; Rong Yang; Kimberly Martinod; Magnus Lindskog; Charles N Serhan; John Inge Johnsen; Per Kogner
Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2010;24(3):906-15.
2010: Ninib Baryawno; Baldur Sveinbjörnsson; Staffan Eksborg; Ching-Shih Chen; Per Kogner; John Inge Johnsen
Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growth.
Cancer research 2010;70(1):266-76.
2009: Hiromi Hanaka; Sven-Christian Pawelzik; John Inge Johnsen; Marija Rakonjac Ryge; Kan Terawaki; Agnes Rasmuson; Baldur Sveinbjörnsson; Martin C Schumacher; Mats Hamberg; Bengt Samuelsson; Per-Johan Jakobsson; Per Kogner; Olof Rådmark
Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(44):18757-62.
2009: Erik G Sköldenberg; Anders Larsson; Ake Jakobson; Fredrik Hedborg; Per Kogner; Rolf H Christofferson; Faranak Azarbayjani
The angiogenic growth factors HGF and VEGF in serum and plasma from neuroblastoma patients.
Anticancer research 2009;29(8):3311-9.
2009: John Inge Johnsen; Per Kogner; Ami Albihn; Marie Arsenian Henriksson
Embryonal neural tumours and cell death.
Apoptosis : an international journal on programmed cell death 2009;14(4):424-38.
2009: Annica Wilzén; Staffan Nilsson; Rose-Marie Sjöberg; Per Kogner; Tommy Martinsson; Frida Abel
The Phox2 pathway is differentially expressed in neuroblastoma tumors, but no mutations were found in the candidate tumor suppressor gene PHOX2A.
International journal of oncology 2009;34(3):697-705.
2009: Géraldine Giraud; Torbjörn Ramqvist; Diana V Pastrana; Vincent Pavot; Cecilia Lindau; Per Kogner; Abiel Orrego; Christopher B Buck; Tobias Allander; Stefan Holm; Bengt Gustavsson; Tina Dalianis
DNA from KI, WU and Merkel cell polyomaviruses is not detected in childhood central nervous system tumours or neuroblastomas.
PloS one 2009;4(12):e8239.
2009: Kaisa Thorell; Annika Bergman; Helena Carén; Staffan Nilsson; Per Kogner; Tommy Martinsson; Frida Abel
Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genes.
BMC medical genomics 2009;2():53.
2008: Helena Carén; Frida Abel; Per Kogner; Tommy Martinsson
High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours.
The Biochemical journal 2008;416(2):153-9.
2008: Emma Hovén; Malin Anclair; Ulf Samuelsson; Per Kogner; Krister K Boman
The influence of pediatric cancer diagnosis and illness complication factors on parental distress.
Journal of pediatric hematology/oncology 2008;30(11):807-14.
2008: Ninib Baryawno; Baldur Sveinbjörnsson; Staffan Eksborg; Abiel Orrego; Lova Segerström; Carl Otto Oqvist; Stefan Holm; Bengt Gustavsson; Bertil Kågedal; Per Kogner; John Inge Johnsen
Tumor-growth-promoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targets.
Neuro-oncology 2008;10(5):661-74.
2008: Baldur Sveinbjörnsson; Agnes Rasmuson; Ninib Baryawno; Min Wan; Ingvild Pettersen; Frida Ponthan; Abiel Orrego; Jesper Z Haeggström; John Inge Johnsen; Per Kogner
Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapy.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008;22(10):3525-36.
2008: Janos Geli; Per Kogner; Fredrik Lanner; Natalia Natalishvili; Claes Juhlin; Nimrod Kiss; Geoffrey J Clark; Tomas J Ekström; Filip Farnebo; Catharina Larsson
Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma.
International journal of cancer. Journal international du cancer 2008;123(2):389-94.
2008: John Inge Johnsen; Lova Segerström; Abiel Orrego; L H M Elfman; Marie Henriksson; B Kågedal; Staffan Eksborg; Baldur Sveinbjörnsson; Per Kogner
Inhibitors of mammalian target of rapamycin downregulate MYCN protein expression and inhibit neuroblastoma growth in vitro and in vivo.
Oncogene 2008;27(20):2910-22.
2008: Anna De Geer; Lena-Maria Carlson; Per Kogner; Jelena Levitskaya
Soluble factors released by activated cytotoxic T lymphocytes interfere with death receptor pathways in neuroblastoma.
Cancer immunology, immunotherapy : CII 2008;57(5):731-43.
2008: Cecilia Krona; Helena Carén; Rose-Marie Sjöberg; Bengt Sandstedt; Genevieve Laureys; Per Kogner; Tommy Martinsson
Analysis of neuroblastoma tumour progression; loss of PHOX2B on 4p13 and 17q gain are early events in neuroblastoma tumourigenesis.
International journal of oncology 2008;32(3):575-83.
2008: Lena-Maria Carlson; Sven Påhlman; Anna De Geer; Per Kogner; Jelena Levitskaya
Differentiation induced by physiological and pharmacological stimuli leads to increased antigenicity of human neuroblastoma cells.
Cell research 2008;18(3):398-411.
2008: Helena Carén; Jennie Erichsen; Linda Olsson; Charlotta Enerbäck; Rose-Marie Sjöberg; Jonas Abrahamsson; Per Kogner; Tommy Martinsson
High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene.
BMC genomics 2008;9():353.
2007: Helena Carén; Susanne Fransson; Katarina Ejeskär; Per Kogner; Tommy Martinsson
Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumours.
British journal of cancer 2007;97(10):1416-24.
2007: Malin Wickström; John Inge Johnsen; Frida Ponthan; Lova Segerström; Baldur Sveinbjörnsson; Magnus Lindskog; Henrik Lövborg; Kristina Viktorsson; Rolf Lewensohn; Per Kogner; Rolf Larsson; Joachim Gullbo
The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivo.
Molecular cancer therapeutics 2007;6(9):2409-17.
2007: Janos Geli; Nimrod Kiss; Fredrik Lanner; Theodoros Foukakis; Natalia Natalishvili; Olle Larsson; Per Kogner; Anders Höög; Geoffrey J Clark; Tomas J Ekström; Martin Bäckdahl; Filip Farnebo; Catharina Larsson
The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma.
Endocrine-related cancer 2007;14(1):125-34.
2007: Frida Ponthan; Malin Wickström; Helena Gleissman; Ole M Fuskevåg; Lova Segerström; Baldur Sveinbjörnsson; Christopher P F Redfern; Staffan Eksborg; Per Kogner; John Inge Johnsen
Celecoxib prevents neuroblastoma tumor development and potentiates the effect of chemotherapeutic drugs in vitro and in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(3):1036-44.
2007: Hans Jacobsson; Per M Hellström; Per Kogner; Stig A Larsson
Different concentrations of I-123 MIBG and In-111 pentetreotide in the two main liver lobes in children: persisting regional functional differences after birth?
Clinical nuclear medicine 2007;32(1):24-8.
2006: Liv Tone Eliassen; Gerd Berge; Arild Leknessund; Mari Wikman; Inger Lindin; Cecilie Løkke; Frida Ponthan; John Inge Johnsen; Baldur Sveinbjørnsson; Per Kogner; Trond Flaegstad; Øystein Rekdal
The antimicrobial peptide, lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo.
International journal of cancer. Journal international du cancer 2006;119(3):493-500.
2006: Magnus Lindskog; Helena Gleissman; Frida Ponthan; Juan Castro; Per Kogner; John Inge Johnsen
Neuroblastoma cell death in response to docosahexaenoic acid: sensitization to chemotherapy and arsenic-induced oxidative stress.
International journal of cancer. Journal international du cancer 2006;118(10):2584-93.
2006: Radmila Santic; Katrin Fenninger; Kerstin Graf; Rainer Schneider; Cornelia Hauser-Kronberger; Freimut H Schilling; Per Kogner; Manfred Ratschek; Neil Jones; Wolfgang Sperl; Barbara Kofler
Gangliocytes in neuroblastic tumors express alarin, a novel peptide derived by differential splicing of the galanin-like peptide gene.
Journal of molecular neuroscience : MN 2006;29(2):145-52.
2005: John Inge Johnsen; Magnus Lindskog; Frida Ponthan; Ingvild Pettersen; Lotta Elfman; Abiel Orrego; Baldur Sveinbjörnsson; Per Kogner
NSAIDs in neuroblastoma therapy.
Cancer letters 2005;228(1-2):195-201.
2005: Magnus Lindskog; Christian Spenger; Tomas Klason; Jüri Jarvet; Astrid Gräslund; John Inge Johnsen; Frida Ponthan; Lena Douglas; Bo Nordell; Per Kogner
Proton magnetic resonance spectroscopy in neuroblastoma: current status, prospects and limitations.
Cancer letters 2005;228(1-2):247-55.
2005: Alexandra Berger; Radmila Santic; Cornelia Hauser-Kronberger; Freimut H Schilling; Per Kogner; Manfred Ratschek; Agnes Gamper; Neil Jones; Wolfgang Sperl; Barbara Kofler
Galanin and galanin receptors in human cancers.
Neuropeptides 2005;39(3):353-9.
2005: Frida Abel; Rose-Marie Sjöberg; Staffan Nilsson; Per Kogner; Tommy Martinsson
Imbalance of the mitochondrial pro- and anti-apoptotic mediators in neuroblastoma tumours with unfavourable biology.
European journal of cancer (Oxford, England : 1990) 2005;41(4):635-46.
2004: John Inge Johnsen; Ingvild Pettersen; Frida Ponthan; Baldur Sveinbjørnsson; Trond Flaegstad; Per Kogner
Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAIL.
International journal of oncology 2004;25(6):1849-57.
2004: Dewi Astuti; Mark Morris; Cecilia Krona; Frida Abel; Dean Gentle; Tommy Martinsson; Per Kogner; Hartmut P H Neumann; R Voutilainen; Charis Eng; P Rustin; Farida Latif; Eamonn R Maher
Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma.
British journal of cancer 2004;91(10):1835-41.
2004: John Inge Johnsen; Magnus Lindskog; Frida Ponthan; Ingvild Pettersen; Lotta Elfman; Abiel Orrego; Baldur Sveinbjörnsson; Per Kogner
Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo.
Cancer research 2004;64(20):7210-5.
2004: Magnus Lindskog; Christian Spenger; Jüri Jarvet; Astrid Gräslund; Per Kogner
Predicting resistance or response to chemotherapy by proton magnetic resonance spectroscopy in neuroblastoma.
Journal of the National Cancer Institute 2004;96(19):1457-66.
2004: Krister K Boman; Jonas Viksten; Per Kogner; Ulf Samuelsson
Serious illness in childhood: the different threats of cancer and diabetes from a parent perspective.
The Journal of pediatrics 2004;145(3):373-9.
2004: Bertil Kågedal; Anita Kullman; Liselotte Lenner; catarina Träger; Per Kogner; Malin Farnebäck
Pterin-dependent tyrosine hydroxylase mRNA is not expressed in human melanocytes or melanoma cells.
Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society 2004;17(4):346-51.
2004: Dewi Astuti; Nancy Fernandes da Silva; Ashraf Dallol; Dean Gentle; Tommy Martinsson; Per Kogner; Richard G Grundy; Takeshi Kishida; Masahiro Yao; Farida Latif; Eamonn R Maher
SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinoma.
British journal of cancer 2004;90(2):515-21.
2003: Silvia Vertuani; Anna De Geer; Victor Levitsky; Per Kogner; Rolf Kiessling; Jelena Levitskaya
Retinoids act as multistep modulators of the major histocompatibility class I presentation pathway and sensitize neuroblastomas to cytotoxic lymphocytes.
Cancer research 2003;63(22):8006-13.
2003: Frida Ponthan; Magnus Lindskog; Nina Karnehed; Juan Castro; Per Kogner
Evaluation of anti-tumour effects of oral fenretinide (4-HPR) in rats with human neuroblastoma xenografts.
Oncology reports 2003;10(5):1587-92.
2003: Frida Ponthan; John Inge Johnsen; Lena Klevenvall; Juan Castro; Per Kogner
The synthetic retinoid RO 13-6307 induces neuroblastoma differentiation in vitro and inhibits neuroblastoma tumour growth in vivo.
International journal of cancer. Journal international du cancer 2003;104(4):418-24.
2003: Cecilia Krona; Katarina Ejeskär; Frida Abel; Per Kogner; Jill Bjelke; Elin Björk; Rose-Marie Sjöberg; Tommy Martinsson
Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2.
Oncogene 2003;22(15):2343-51.
2003: Irina Svechnikova; Steven G Gray; Jurgita Kundrotiene; Frida Ponthan; Per Kogner; Tomas J Ekström
Apoptosis and tumor remission in liver tumor xenografts by 4-phenylbutyrate.
International journal of oncology 2003;22(3):579-88.
2003: Magnus Lindskog; Per Kogner; Frida Ponthan; Petra Schweinhardt; Bengt Sandstedt; T Heiden; Gunther Helms; Christian Spenger
Noninvasive estimation of tumour viability in a xenograft model of human neuroblastoma with proton magnetic resonance spectroscopy (1H MRS).
British journal of cancer 2003;88(3):478-85.
2003: catarina Träger; Per Kogner; Magnus Lindskog; Frida Ponthan; Anita Kullman; Bertil Kågedal
Quantitative analysis of tyrosine hydroxylase mRNA for sensitive detection of neuroblastoma cells in blood and bone marrow.
Clinical chemistry 2003;49(1):104-12.
2002: Alexandra Berger; Camilla Tuechler; Dietmar Almer; Per Kogner; Manfred Ratschek; Reinhold Kerbl; Tiina P Iismaa; Neil Jones; Wolfgang Sperl; Barbara Kofler
Elevated expression of galanin receptors in childhood neuroblastic tumors.
Neuroendocrinology 2002;75(2):130-8.
2002: B Fröstad; Edneia Tani; Otte Brosjö; Lambert Skoog; Per Kogner
Fine needle aspiration cytology in the diagnosis and management of children and adolescents with Ewing sarcoma and peripheral primitive neuroectodermal tumor.
Medical and pediatric oncology 2002;38(1):33-40.
2001: Frida Ponthan; Per Kogner; P Bjellerup; L Klevenvall; M Hassan
Bioavailability and dose-dependent anti-tumour effects of 9-cis retinoic acid on human neuroblastoma xenografts in rat.
British journal of cancer 2001;85(12):2004-9.
2001: Dewi Astuti; Angelo Agathanggelou; Sofia Honorio; Ashraf Dallol; Tommy Martinsson; Per Kogner; Carole Cummins; Hartmut P H Neumann; R Voutilainen; Patricia Dahia; Charis Eng; Eamonn R Maher; Farida Latif
RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
Oncogene 2001;20(51):7573-7.
2001: Göran Dahllöf; P Borgström; G Lundell; Hans Jacobsson; Per Kogner
Severe oral mucositis after therapeutic administration of [131I]MIBG in a child with neuroblastoma.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2001;92(4):420-3.
2001: Katarina Ejeskär; Rose-Marie Sjöberg; Frida Abel; Per Kogner; P F Ambros; Tommy Martinsson
Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours.
Medical and pediatric oncology 2001;36(1):61-6.
2001: Freimut H Schilling; Peter F Ambros; H Bihl; T Martinsson; Inge M Ambros; P Borgström; Hans Jacobsson; U G Falkmer; Jörn Treuner; Per Kogner
Absence of somatostatin receptor expression in vivo is correlated to di- or tetraploid 1p36-deleted neuroblastomas.
Medical and pediatric oncology 2001;36(1):56-60.
2001: Frida Ponthan; P Borgström; M Hassan; E Wassberg; Christopher P F Redfern; Per Kogner
The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo.
Medical and pediatric oncology 2001;36(1):127-31.
2000: Freimut H Schilling; H Bihl; Hans Jacobsson; Peter F Ambros; T Martinsson; P Borgström; Kerstin Schwarz; Inge M Ambros; Jörn Treuner; Per Kogner
Combined (111)In-pentetreotide scintigraphy and (123)I-mIBG scintigraphy in neuroblastoma provides prognostic information.
Medical and pediatric oncology 2000;35(6):688-91.
2000: Gunn Eli Kimo Jørgensen; John Inge Johnsen; Frida Ponthan; Per Kogner; Trond Flaegstad; Terje Traavik
Human polyomavirus BK (BKV) and neuroblastoma: mechanisms of oncogenic action and possible strategy for novel treatment.
Medical and pediatric oncology 2000;35(6):593-6.
2000: Steven G Gray; Wolfgang Hartmann; T Eriksson; C Ekstrom; S Holm; S Kytola; Dietrich von Schweinitz; Torsten Pietsch; Catharina Larsson; Per Kogner; Bengt Sandstedt; T J Ekstrom
Expression of genes involved with cell cycle control, cell growth and chromatin modification are altered in hepatoblastomas.
International journal of molecular medicine 2000;6(2):161-9.
2000: P Bjellerup; E Theodorsson; H Jörnvall; Per Kogner
Limited neuropeptide Y precursor processing in unfavourable metastatic neuroblastoma tumours.
British journal of cancer 2000;83(2):171-6.
2000: Steven G Gray; T Eriksson; C Ekström; S Holm; Dietrich von Schweinitz; Per Kogner; Bengt Sandstedt; T Pietsch; Tomas J Ekström
Altered expression of members of the IGF-axis in hepatoblastomas.
British journal of cancer 2000;82(9):1561-7.
2000: Katarina Ejeskär; Frida Abel; Rose-Marie Sjöberg; J Bäckström; Per Kogner; Tommy Martinsson
Fine mapping of the human preprocortistatin gene (CORT) to neuroblastoma consensus deletion region 1p36.3-->p36.2, but absence of mutations in primary tumors.
Cytogenetics and cell genetics 2000;89(1-2):62-6.
1999: Frida Abel; Katarina Ejeskär; Per Kogner; Tommy Martinsson
Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2(SSTR2) gene at 17q24.
British journal of cancer 1999;81(8):1402-9.
1999: Essam Refai; C Jonsson; Mats Andersson; Hans Jacobsson; S Larsson; Per Kogner; M Hassan
Biodistribution of liposomal 131I-VIP in rat using gamma camera.
Nuclear medicine and biology 1999;26(8):931-6.
1999: P Borgström; M Hassan; E Wassberg; Essam Refai; C Jonsson; S A Larsson; Hans Jacobsson; Per Kogner
The somatostatin analogue octreotide inhibits neuroblastoma growth in vivo.
Pediatric research 1999;46(3):328-32.
1999: Katarina Ejeskär; Rose-Marie Sjöberg; Per Kogner; Tommy Martinsson
Variable expression and absence of mutations in p73 in primary neuroblastoma tumors argues against a role in neuroblastoma development.
International journal of molecular medicine 1999;3(6):585-9.
1999: B Fröstad; Tommy Martinsson; Edneia Tani; U Falkmer; Catarina Darnfors; Lambert Skoog; Per Kogner
The use of fine-needle aspiration cytology in the molecular characterization of neuroblastoma in children.
Cancer 1999;87(2):60-8.
1999: Trond Flaegstad; Per Arne Andresen; John Inge Johnsen; S K Asomani; Gunn Eli Kimo Jørgensen; S Vignarajan; Anita K Kjuul; Per Kogner; Terje Traavik
A possible contributory role of BK virus infection in neuroblastoma development.
Cancer research 1999;59(5):1160-3.
1999: Anna Fredriksson; Peter Johnström; Jan-Olov Thorell; G von Heijne; M Hassan; Staffan Eksborg; Per Kogner; P Borgström; Martin Ingvar; Sharon Stone-Elander
In vivo evaluation of the biodistribution of 11C-labeled PD153035 in rats without and with neuroblastoma implants.
Life sciences 1999;65(2):165-74.
1998: Ursula Eder; Reiner Fischer-Colbrie; Per Kogner; B Leitner; P Bjellerup; H Winkler
Levels and molecular forms of chromogranins in human childhood neuroblastomas and ganglioneuromas.
Neuroscience letters 1998;253(1):17-20.
1998: Katarina Ejeskär; H Aburatani; J Abrahamsson; Per Kogner; Tommy Martinsson
Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT gene.
British journal of cancer 1998;77(11):1787-91.
1998: B Fröstad; Edneia Tani; Per Kogner; S Maeda; O Björk; Lambert Skoog
The clinical use of fine needle aspiration cytology for diagnosis and management of children with neuroblastic tumours.
European journal of cancer (Oxford, England : 1990) 1998;34(4):529-36.
1998: X Li; Per Kogner; Bengt Sandstedt; O A Haas; Tomas J Ekström
Promoter-specific methylation and expression alterations of igf2 and h19 are involved in human hepatoblastoma.
International journal of cancer. Journal international du cancer 1998;75(2):176-80.
1997: T Svensson; M Rydén; Freimut H Schilling; C Dominici; R Sehgal; C F Ibáñez; Per Kogner
Coexpression of mRNA for the full-length neurotrophin receptor trk-C and trk-A in favourable neuroblastoma.
European journal of cancer (Oxford, England : 1990) 1997;33(12):2058-63.
1997: Per Kogner; P Borgström; P Bjellerup; Freimut H Schilling; Essam Refai; C Jonsson; C Dominici; E Wassberg; H Bihl; Hans Jacobsson; E Theodorsson; M Hassan
Somatostatin in neuroblastoma and ganglioneuroma.
European journal of cancer (Oxford, England : 1990) 1997;33(12):2084-9.
1997: Tommy Martinsson; Rose-Marie Sjöberg; K Hallstensson; Margareta Nordling; F Hedborg; Per Kogner
Delimitation of a critical tumour suppressor region at distal 1p in neuroblastoma tumours.
European journal of cancer (Oxford, England : 1990) 1997;33(12):1997-2001.
1997: Tommy Martinsson; Rose-Marie Sjöberg; F Hedborg; Per Kogner
Homozygous deletion of the neurofibromatosis-1 gene in the tumor of a patient with neuroblastoma.
Cancer genetics and cytogenetics 1997;95(2):183-9.
1996: M Rydén; R Sehgal; C Dominici; F H Schilling; Carlos F Ibáñez; Per Kogner
Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis.
British journal of cancer 1996;74(5):773-9.
1995: Tommy Martinsson; Rose-Marie Sjöberg; Fredrik Hedborg; Per Kogner
Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
Cancer research 1995;55(23):5681-6.
1995: Per Kogner
Neuropeptides in neuroblastomas and ganglioneuromas.
Progress in brain research 1995;104():325-38.
1995: Per Kogner; P Bjellerup; T Svensson; E Theodorsson
Pancreastatin immunoreactivity in favourable childhood neuroblastoma and ganglioneuroma.
European journal of cancer (Oxford, England : 1990) 1995;31A(4):557-60.
1995: P Bjellerup; E Theodorsson; Per Kogner
Somatostatin and vasoactive intestinal peptide (VIP) in neuroblastoma and ganglioneuroma: chromatographic characterisation and release during surgery.
European journal of cancer (Oxford, England : 1990) 1995;31A(4):481-5.
1994: Per Kogner; O Björk; E Theodorsson
Plasma neuropeptide Y in healthy children: influence of age, anaesthesia and the establishment of an age-adjusted reference interval.
Acta paediatrica (Oslo, Norway : 1992) 1994;83(4):423-7.
1994: Per Kogner; G Barbany; H Persson; Stefan Söderhäll; L Ahström; O Björk
Expression of nerve growth factor receptor mRNAs and clinical response to retinoic acid in neuroblastoma.
Progress in clinical and biological research 1994;385():147-53.
1994: Per Kogner; G Barbany; O Björk; Manuel A Castello; Alberto Donfrancesco; U G Falkmer; Fredrik Hedborg; H Kouvidou; H Persson; G Raschella
Trk mRNA and low affinity nerve growth factor receptor mRNA expression and triploid DNA content in favorable neuroblastoma tumors.
Progress in clinical and biological research 1994;385():137-45.
1993: Per Kogner; G Barbany; C Dominici; Manuel A Castello; G Raschellá; H Persson
Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis.
Cancer research 1993;53(9):2044-50.
1993: Per Kogner; O Björk; E Theodorsson
Neuropeptide Y in neuroblastoma: increased concentration in metastasis, release during surgery, and characterization of plasma and tumor extracts.
Medical and pediatric oncology 1993;21(5):317-22.
1992: Per Kogner; Anders Ericsson-Dahlstrand; G Barbany; H Persson; E Theodorsson; O Björk
Neuropeptide Y (NPY) synthesis in lymphoblasts and increased plasma NPY in pediatric B-cell precursor leukemia.
Blood 1992;80(5):1324-9.
1992: Fredrik Hedborg; P G Lindgren; I Johansson; Per Kogner; B O Samuelsson; A N Bekassy; L Olsen; A Kreuger; Sven Påhlman
N-myc gene amplification in neuroblastoma: a clinical approach using ultrasound guided cutting needle biopsies collected at diagnosis.
Medical and pediatric oncology 1992;20(4):292-300.
1991: Per Kogner; E Theodorsson; O Björk
Plasma neuropeptide Y (NPY): a novel marker of neuroblastoma.
Progress in clinical and biological research 1991;366():367-73.
1991: Per Kogner; O Björk; Fredrik Hedborg; Agneta Nordenskjöld; Magnus Nordenskjöld; Stefan Söderhäll; E Theodorsson
Characterization of neuropeptide Y in pediatric neural crest tumors: relation to tumor malignancy and genetic findings.
Progress in clinical and biological research 1991;366():351-7.
1990: Per Kogner; O Björk; E Theodorsson
Neuropeptide Y as a marker in pediatric neuroblastoma.
Pediatric pathology / affiliated with the International Paediatric Pathology Association 1990;10(1-2):207-16.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.